BackHLS Therapeutics Overview

HLS Therapeutics Receivables

Track HLS Therapeutics's receivables ($8.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$8.51M
↓ 5.98% YoYΔ $-541000.00 vs prior year quarter

Peer trimmed avg / median

Loading

HLS Therapeutics Receivables History

Loading

HLS Therapeutics vs. peers: Receivables Comparison

Loading

HLS Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

HLS Therapeutics (HLTRF) FAQ

HLS Therapeutics (HLTRF) currently reports a receivables of $8.5M as of June 2026. That compares with $9M in the prior-year period — down 6.0% year over year. Use the charts on this page to explore HLS Therapeutics's receivables history and peer comparisons.

HLS Therapeutics's receivables decreased from $9M to $8.5M — a 6.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HLS Therapeutics reported $8.5M in receivables as of June 2026. That compares with $9M in the prior-year period — down 6.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $8.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HLS Therapeutics, and consider following HLTRF for alerts when major investors trade the stock.